BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10415108)

  • 21. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
    Shipley JM; Waxman DJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(2):87-97. PubMed ID: 16257430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells.
    Krishnan V; Porter W; Santostefano M; Wang X; Safe S
    Mol Cell Biol; 1995 Dec; 15(12):6710-9. PubMed ID: 8524236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of CYP1A1 expression is involved in unresponsiveness of the human hepatoma cell line SK-HEP-1 to dioxin.
    Shiizaki K; Ohsako S; Koyama T; Nagata R; Yonemoto J; Tohyama C
    Toxicol Lett; 2005 Dec; 160(1):22-33. PubMed ID: 16054781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription.
    Beischlag TV; Perdew GH
    J Biol Chem; 2005 Jun; 280(22):21607-11. PubMed ID: 15837795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells.
    Spink DC; Katz BH; Hussain MM; Pentecost BT; Cao Z; Spink BC
    Carcinogenesis; 2003 Dec; 24(12):1941-50. PubMed ID: 12970067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant cultures of human endometrium.
    Bofinger DP; Feng L; Chi LH; Love J; Stephen FD; Sutter TR; Osteen KG; Costich TG; Batt RE; Koury ST; Olson JR
    Toxicol Sci; 2001 Aug; 62(2):299-314. PubMed ID: 11452143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cytochrome P-450 (CYP) 1B1 in mouse Hepa-1 variant cell lines: A possible role for aryl hydrocarbon receptor nuclear translocator (ARNT) as a suppressor of CYP1B1 gene expression.
    Eltom SE; Zhang L; Jefcoate CR
    Mol Pharmacol; 1999 Mar; 55(3):594-604. PubMed ID: 10051545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition.
    Duan R; Porter W; Samudio I; Vyhlidal C; Kladde M; Safe S
    Mol Endocrinol; 1999 Sep; 13(9):1511-21. PubMed ID: 10478842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of transient expression of the oestrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells.
    Wang WL; Thomsen JS; Porter W; Moore M; Safe S
    Br J Cancer; 1996 Feb; 73(3):316-22. PubMed ID: 8562336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
    Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
    Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonresponsiveness to 2,3,7,8-tetrachlorodibenzo-p-dioxin of transforming growth factor beta1 and CYP 1A1 gene expression in rat liver fat-storing cells.
    Riebniger D; Schrenk D
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):251-60. PubMed ID: 9772220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-talk between 2,3,7,8-tetrachlorodibenzo-p-dioxin and testosterone signal transduction pathways in LNCaP prostate cancer cells.
    Jana NR; Sarkar S; Ishizuka M; Yonemoto J; Tohyama C; Sone H
    Biochem Biophys Res Commun; 1999 Mar; 256(3):462-8. PubMed ID: 10080920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells.
    Castro-Rivera E; Wormke M; Safe S
    Mol Cell Endocrinol; 1999 Apr; 150(1-2):11-21. PubMed ID: 10411295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism-based polycyclic aromatic acetylene inhibition of CYP1B1 in 10T1/2 cells potentiates aryl hydrocarbon receptor activity.
    Alexander DL; Zhang L; Foroozesh M; Alworth WL; Jefcoate CR
    Toxicol Appl Pharmacol; 1999 Dec; 161(2):123-39. PubMed ID: 10581206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
    Sulentic CE; Holsapple MP; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation status of cultured murine keratinocytes modulates induction of genes responsive to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Jones CL; Reiners JJ
    Arch Biochem Biophys; 1997 Nov; 347(2):163-73. PubMed ID: 9367521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.
    Khan S; Barhoumi R; Burghardt R; Liu S; Kim K; Safe S
    Mol Endocrinol; 2006 Sep; 20(9):2199-214. PubMed ID: 16675542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Cyp1a1 induction by dioxin as a function of cell cycle phase.
    Santini RP; Myrand S; Elferink C; Reiners JJ
    J Pharmacol Exp Ther; 2001 Nov; 299(2):718-28. PubMed ID: 11602686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells.
    Ricci MS; Toscano DG; Mattingly CJ; Toscano WA
    J Biol Chem; 1999 Feb; 274(6):3430-8. PubMed ID: 9920887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Wang WL; Porter W; Burghardt R; Safe SH
    Carcinogenesis; 1997 May; 18(5):925-33. PubMed ID: 9163677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.